Moffitt Cancer Center 19th Annual Clinical Breakthroughs and Challenges in Hematologic Malignancies 2024
Format: 14 videos + 1 pdf, size: 3.78 GB
Course Audience: hematologist, oncologist
Overview:
OVERVIEW
1. Hear the latest updates from leading experts in the field including updates from the latest ASH meeting in December 2023.
2. Engage with colleagues in a world class resort and relaxed atmosphere.
LEARNING OBJECTIVES
- Discuss treatment options available for high risk MDS patients
- Examine new immune based therapies, including CAR T-cell therapy, in the treatment of multiple myeloma
- Describe therapeutic and molecular strategies for managing patients with Non-Hodgkin’s lymphoma
- Examine the management of older adult patients with AML
- Recognize some of the newer issues affecting the care of Hematology patients
TARGET AUDIENCE
This conference is designed specifically for hematologists, medical oncologists, pharmacists, pharmacy techs, fellows, advanced practice professionals, oncology nurses and other healthcare professionals who are interested in this field.
FINAL.Heme-Conference-AGENDA-2024-v21 (PDF Format)
Hot Off the Press Lymphoid Diseases (Video MP4 Format)Hot Off the Press Myeloid Diseases (Video MP4 Format)Hot Off the Press Plasma Cell Dyscrasias (Video MP4 Format)Lymphoid Malignancies Debate Harnessing the Immune System to Manage Relapsed Refractory Diffuse Large B Cell Lymphom No (Video MP4 Format)Lymphoid Malignancies Debate Harnessing the Immune System to Manage Relapsed Refractory Diffuse Large B Cell Lymphom Yes (Video MP4 Format)Lymphoid Malignancies Interactive Case Discussion Optimal Management of Patients with CLL (Video MP4 Format)Lymphoid Malignancies State of the Art Frontline Treatment of Advanced Stage Hodgkin Lymphoma (Video MP4 Format)Multiple Myeloma Debate Response-adapted approach to transplant in newly diagnosed MM are we there yet No (Video MP4 Format)Multiple Myeloma Debate Response-adapted approach to transplant in newly diagnosed MM are we there yet Yes (Video MP4 Format)Multiple Myeloma Interactive Case Discussion Optimal timing of CART-cell therapy in myeloma (Video MP4 Format)Multiple Myeloma State of the Art Bi-specifics antibodies in myeloma Which How When (Video MP4 Format)Myeloid Malignancies Debate- Worst of the worst- Should we transplant patients with p53 mutant MDS or AML Yes (Video MP4 Format)Myeloid Malignancies Interactive Case Discussion- Optimal use of targeted therapy for the elderly or unfit AML patient (Video MP4 Format)Myeloid Malignancies State of the Art- Making Sense of the New Classification Systems for MDS (Video MP4 Format)